Tuesday, 13 Nov 2018
Category: biotech

Interview with Priscilla Chan: Her super-donor origin story

Priscilla Chan is so much more than Mark Zuckerberg’s wife. A teacher, doctor, and now one of the world’s top philanthropists, she’s a dexterous empath determined to help. We’ve all heard Facebook’s dorm-room origin story, but Chan’s epiphany of impact came on a playground. In this touching interview this week at TechCrunch Disrupt SF, Chan […]

HP is ‘printing’ drugs for the CDC to speed up antibiotic testing

At least 2 million people in the U.S. become infected with so-called “super bugs” and at least 23,000 people die as a direct result of these infections each year, according to the Centers for Disease Control (CDC). Now, HP’s Biohacker technology is working with the CDC on a pilot program to “print” and test antibiotics […]

Home run exits happen stealthily for biotech

Joanna Glasner Contributor More posts by this contributor While tech waffles on going public, biotech IPOs boom Shoe startups aren’t dragging their feet Startup exit tallies commonly underestimate biotech returns. Unlike most tech deals, the biggest profits in bio often come long after an IPO or acquisition. Take Juno Therapeutics, a publicly traded cancer immunology company […]

Zbiotics says it’s bioengineered a hangover cure

Y Combinator backed Zbiotics has spend two years developing what they’re billing as the world’s first genetically engineered probiotic. The startup’s initial product isn’t exactly world-changing but it might just save your day — given they’ve invented an elixir of ‘next day’ life: Aka a hangover cure. Although you actually have to take it before — or, well, during […]

While tech waffles on going public, biotech IPOs boom

For people who make investment decisions based on revenues and projected earnings, biotech IPOs are kind of a non-starter. Not only are new market entrants universally unprofitable, most have zero revenue. Going public is mostly a means to raise money for clinical trials, with red ink expected for years to come. That pattern may be […]

CRISPR DNA editing may cause serious genetic damage, researchers warn

CRISPR-Cas9, the gene-editing tool that is currently the darling of biotech and many other fields, may not be quite as miraculous as early tests suggested. A new study finds that what scientists thought of as a scalpel may be more like a felling axe, causing damage hundreds of times what was previously observed. Before anyone […]

Implantable 3D-printed organs could be coming sooner than you think

At MBC Biolabs, an incubator for biotech startups in San Francisco’s Dogpatch neighborhood, a team of scientists and interns working for the small startup Prellis Biologics have just taken a big step on the path toward developing viable 3D-printed organs for humans. The company, which was founded in 2016 by research scientists Melanie Matheu and […]

Priscilla Chan to discuss Chan Zuckerberg Initiative at Disrupt SF

The Chan Zuckerberg Initiative is one of the biggest philanthropic organizations in the world, and the most technology-forward foundations in history. By integrating technology, CZI believes it can affect social change at a much more rapid pace than by simply infusing initiatives with cash. With that said, we’re absolutely thrilled to have Priscilla Chan join us […]